Trethera Corporation to present at BIO Investor Forum

Beverly Hills, CA, 6 October 2016 – Trethera, a biotechnology company focused on the discovery and development of innovative small molecules for the treatment of hematological and solid tumors will be presenting at the BIO Investor Forum, San Francisco, USA, 18-19 October 2016.

Johanna Holldack, Trethera’s CEO, will be giving a Company Presentation on Tuesday, 18 October 2016 at 15:00 in the Yorkshire presentation room.

For more information on Trethera’s presentations or for media enquiries, please contact